German researchers have devised a new technology for examining the purity of water constantly. In contrast to the periodic evaluation of water samples, the AquaBioTox scheme will generate a solution for the continual live validation of drinking water.
Stretchable silicon electronics that offer the computing power of rigid chips could make their way into Reebok's athletic apparel shortly. The company and MC10, a start up maker of flexible electronics, are working together to develop sportswear that incorporates electronics to monitor athletes' health and performance during training and rehabilitation.
The US researchers have developed a novel biosensor to identify harmful viruses such as Marburg and Ebola. The researchers used plasmonic nanohole arrays to develop the sensor. The biosensor can be used in airports and places where man-made or natural outbreaks can occur.
A student team at UT Dallas used common bacteria to detect the presence of harmful petrochemicals in seafood or water. The team consisting of graduate, undergraduate, and high school students has developed sensors that emit a fluorescent protein when it tests positive for a number of petrochemicals.
The European consortium consisting of TU Delft, the University of Edinburgh, ST Microelectronics, and the National Physical Laboratory (NPL) is aiding in the application and development of a new ultrafast camera.
Edwards Lifesciences announced that it has received the CE mark from the European Union for its VolumeView, and EV1000 platforms.
The Air Force Research Laboratory is collaborating with industry for advancing a system that has the potential to detect a military personnel’s health condition under battle constraint, by using wearable or digestible sensors, comments Elizabeth Long of the 711th Human Performance Wing’s Air Force.
Novartis is focusing on developing an ingestible smart pill that will produce a signaling impulse, which can further be analyzed for studying the effect of the administered drug on the patient.
Affectiva, a firm that develops technologies to assist people suffering from autism spectrum disorders, has announced at the Future Forward Executive Forum the launch of a beta form of its biosensor named Q Sensor.
Multinational pharmaceutical company Novartis declared it is closing in on producing a pill that once ingested relays patient health parameters as well as its own effect on the patient's body.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.